ENPLUSONE
LIVE

Serial Number

97416660

Owner

ENPLUSONE BIOSCIENCES INC.

Attorney

Brendan J. Hughes

Filing Date

May 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ENPLUSONE Trademark

Serial Number: 97416660

ENPLUSONE is a trademark filed by ENPLUSONE BIOSCIENCES INC. on May 18, 2022. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ENPLUSONE BIOSCIENCES INC. (2 trademarks)

Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

May 18, 2022

Registration Date

Not Registered

Published for Opposition

April 25, 2023

Goods & Services

Scientific research services for research involving ribonucleic acid (RNA) oligonucleotide synthesis

Laboratory apparatus and instruments for extracting ribonucleic acid (RNA) oligonucleotides, other than medical purposes; biotechnology research products and devices for research use and for use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids for scientific research and analysis, namely, biological microscopes, petri dishes used in laboratory research, nucleic acid sequencers for scientific purposes, and laboratory instrument for the detection of pathogens and toxins in a biological sample for use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids for scientific research and analysis; biotechnology research instruments for use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids for scientific research and analysis, sold individually and as a part of kits comprised primarily of biotechnology laboratory research instruments for extracting nucleic acid

Active chemical ingredients for use in the manufacturing of ribonucleic acid (RNA) and nucleic acids; ribonucleic acid (RNA) oligonucleotides for scientific and research use; enzymes for scientific research and use in expression, amplification, modification, purification, isolation, and preparation of nucleic acids for scientific research and analysis, all the foregoing sold individually and as part of kits comprised primarily of enzymes for scientific and research purposes

Filing History

SOU TEAS EXTENSION RECEIVED
Dec 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jun 17, 2025 EX4G
SOU EXTENSION 4 FILED
Jun 17, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 18, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 18, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 20, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 20, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 20, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 7, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 7, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 7, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2023 CNEA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 16, 2023 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Mar 16, 2023 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Mar 16, 2023 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Mar 16, 2023 CPEA
ASSIGNED TO EXAMINER
Mar 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2022 NWOS
NEW APPLICATION ENTERED
May 21, 2022 NWAP